Omnicell Inc
OMCL32.320USD
+0.060+0.19%
Handelsschluss 09/16, 16:00（ET）Kurse um 15 Minuten verzögert
1.50BMarktkapitalisierung
64.98KGV TTM
mehr Informationen über Omnicell Inc Unternehmen
Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.
Unternehmensinformationen
BörsenkürzelOMCL
Name des UnternehmensOmnicell Inc
IPO-datumAug 08, 2001
CEOMr. Randall A. Lipps
Anzahl der mitarbeiter3670
WertpapierartOrdinary Share
GeschäftsjahresendeAug 08
Addresse4220 North Freeway
StadtFORT WORTH
BörseNASDAQ Global Select Consolidated
LandUnited States of America
Postleitzahl76137
Telefon18774159990
Websitehttps://www.omnicell.com/
BörsenkürzelOMCL
IPO-datumAug 08, 2001
CEOMr. Randall A. Lipps
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Randall A. Lipps
Mr. Randall A. Lipps
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
428.14K
-1.93%
Mr. Nnamdi Njoku
Mr. Nnamdi Njoku
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
90.93K
+69.90%
Mr. Robin Gene Seim
Mr. Robin Gene Seim
Independent Director
Independent Director
47.35K
+16.85%
Ms. Joanne B. Bauer
Ms. Joanne B. Bauer
Lead Independent Director
Lead Independent Director
44.90K
+18.74%
Mr. Bruce E. Scott
Mr. Bruce E. Scott
Independent Director
Independent Director
22.97K
+42.59%
Mr. Corey J. Manley
Mr. Corey J. Manley
Executive Vice President, Chief Legal and Administrative Officer
Executive Vice President, Chief Legal and Administrative Officer
18.48K
-13.13%
Mr. Edward Peter Bousa
Mr. Edward Peter Bousa
Independent Director
Independent Director
17.99K
+56.40%
Ms. Mary Garrett
Ms. Mary Garrett
Independent Director
Independent Director
17.18K
+70.20%
Mr. Kaushik (Bobby) Ghoshal
Mr. Kaushik (Bobby) Ghoshal
Independent Director
Independent Director
14.52K
+78.84%
Mr. Baird Radford
Mr. Baird Radford
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Randall A. Lipps
Mr. Randall A. Lipps
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
428.14K
-1.93%
Mr. Nnamdi Njoku
Mr. Nnamdi Njoku
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
90.93K
+69.90%
Mr. Robin Gene Seim
Mr. Robin Gene Seim
Independent Director
Independent Director
47.35K
+16.85%
Ms. Joanne B. Bauer
Ms. Joanne B. Bauer
Lead Independent Director
Lead Independent Director
44.90K
+18.74%
Mr. Bruce E. Scott
Mr. Bruce E. Scott
Independent Director
Independent Director
22.97K
+42.59%
Mr. Corey J. Manley
Mr. Corey J. Manley
Executive Vice President, Chief Legal and Administrative Officer
Executive Vice President, Chief Legal and Administrative Officer
18.48K
-13.13%
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Connected devices, software licenses, and other
120.08M
44.53%
SaaS and Expert Services
63.12M
23.41%
Technical services
61.38M
22.76%
Consumables
25.09M
9.30%
Nach RegionUSD
Name
Umsatz
Anteil
United States
249.26M
92.43%
Rest of the World
20.40M
7.57%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Connected devices, software licenses, and other
120.08M
44.53%
SaaS and Expert Services
63.12M
23.41%
Technical services
61.38M
22.76%
Consumables
25.09M
9.30%
Aktionärsstatistik
Aktualisiert: Fri, Aug 15
Aktualisiert: Fri, Aug 15
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
14.84%
The Vanguard Group, Inc.
12.23%
Dimensional Fund Advisors, L.P.
4.72%
State Street Global Advisors (US)
4.56%
Lazard Asset Management, L.L.C.
3.72%
Andere
59.94%
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
14.84%
The Vanguard Group, Inc.
12.23%
Dimensional Fund Advisors, L.P.
4.72%
State Street Global Advisors (US)
4.56%
Lazard Asset Management, L.L.C.
3.72%
Andere
59.94%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
48.12%
Investment Advisor/Hedge Fund
36.85%
Hedge Fund
13.77%
Research Firm
3.15%
Individual Investor
1.88%
Sovereign Wealth Fund
1.51%
Pension Fund
1.36%
Bank and Trust
0.94%
Family Office
0.05%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
681
49.10M
106.89%
-9.34M
2025Q1
708
50.20M
107.17%
-8.54M
2024Q4
716
48.64M
104.03%
-9.20M
2024Q3
742
47.70M
103.68%
-13.09M
2024Q2
766
48.23M
105.00%
-10.57M
2024Q1
786
47.95M
104.43%
-7.71M
2023Q4
812
47.51M
104.50%
-6.33M
2023Q3
817
49.57M
109.64%
-4.16M
2023Q2
820
48.12M
106.76%
-6.53M
2023Q1
823
48.10M
106.74%
-4.33M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BlackRock Institutional Trust Company, N.A.
6.94M
14.81%
-199.83K
-2.80%
Mar 31, 2025
The Vanguard Group, Inc.
5.56M
11.88%
+11.69K
+0.21%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
1.88M
4.02%
+241.88K
+14.73%
Mar 31, 2025
State Street Global Advisors (US)
2.17M
4.62%
-79.02K
-3.52%
Mar 31, 2025
Lazard Asset Management, L.L.C.
1.65M
3.51%
+3.79K
+0.23%
Mar 31, 2025
Amova Asset Management Co., Ltd.
1.41M
3%
-44.49K
-3.07%
Mar 31, 2025
D. E. Shaw & Co., L.P.
1.40M
2.98%
+455.16K
+48.39%
Mar 31, 2025
Victory Capital Management Inc.
1.68M
3.59%
+154.04K
+10.09%
Mar 31, 2025
Macquarie Investment Management
1.14M
2.44%
+27.97K
+2.51%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Sep 6
Aktualisiert: Sat, Sep 6
Name
Anteil
SPDR S&P Health Care Equipment ETF
2.03%
Global X HealthTech ETF
1.43%
Invesco S&P SmallCap Health Care ETF
1.15%
ROBO Global Healthcare Technology & Innovation ETF
1.14%
Global X Robotics & Artificial Intelligence ETF
0.58%
First Trust Nasdaq AI and Robotics ETF
0.45%
ETC 6 Meridian Low Beta Equity Strategy ETF
0.36%
Fidelity Enhanced Small Cap ETF
0.31%
SPDR S&P Kensho New Economies Composite ETF
0.28%
First Trust Small Cap Value AlphaDEX Fund
0.28%
Mehr Anzeigen
SPDR S&P Health Care Equipment ETF
Anteil2.03%
Global X HealthTech ETF
Anteil1.43%
Invesco S&P SmallCap Health Care ETF
Anteil1.15%
ROBO Global Healthcare Technology & Innovation ETF
Anteil1.14%
Global X Robotics & Artificial Intelligence ETF
Anteil0.58%
First Trust Nasdaq AI and Robotics ETF
Anteil0.45%
ETC 6 Meridian Low Beta Equity Strategy ETF
Anteil0.36%
Fidelity Enhanced Small Cap ETF
Anteil0.31%
SPDR S&P Kensho New Economies Composite ETF
Anteil0.28%
First Trust Small Cap Value AlphaDEX Fund
Anteil0.28%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
